targeted care hair care base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Across cosmetic emulsions, washes, and gels, glycerin is listed as a polyol humectant; its amount is a development guide.

3. Typical use levels (formulation guide)

• For gels and serums, the reference gives 3–8%.
• The formulation record indicates 2–5% for creams.
• The rinse-off use-level reference is 2–4% as a formulation guide.

Add Glycerin in the water phase without melting it first.

4. Regulatory sources & global compliance

• If CosIng lists Glycerin, that listing remains ingredient information; check rules for the intended market and use.
• EU cosmetics rules under Regulation (EC) No 1223/2009 require an assessment of the safety of the final cosmetic containing Glycerin before the finished product is marketed.
• For Glycerin, check the purchased grade against its supplier TDS and review filing requirements in the destination market.

5. Safety & risk assessment

Use the stated level as reference guidance for cosmetic formulation; it provides no evidence that a drug or OTC monograph applies and patch and stability testing remain part of finished-product review.

6. Stability & packaging

Maintain cool, closed, light-protected storage for the bulk material; evaluate packaging against the formula's susceptibility to oxidation; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The cosmetic role of Glycerin is presented as humectant function.

• This reference does not support drug effects, clinical cures, or unsupported product certifications.
• The ingredient note for Glycerin does not substantiate a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• 2–6% is listed for gel-creams in this reference.
• The formulation record indicates 10–30% for dry oils.
• The formulation record indicates 5–15% for balms for the formula.

Add Squalane to the oil phase; no high-shear wax step is required.

4. Regulatory sources & global compliance

• CosIng information about Squalane does not itself authorize a particular grade or finished cosmetic.
• Regulation (EC) No 1223/2009 sets the requirement for a safety assessment of the finished cosmetic containing Squalane at the level of the finished cosmetic product.
• Establish grade-specific details for Squalane from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; it makes no claim of drug or OTC authorization with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Protect sealed bulk from warmth and direct light; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; check the finished formula and its packaging together.

7. Claims language (Do / Don’t)

• The cosmetic role of Squalane is presented as a light-emollient role.

• The listed information does not substantiate claims of drug activity, a clinical cure, or an undocumented product certification.
• The ingredient record for Squalane is not evidence for skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

Shea butter is included as a triglyceride butter for cushioning creams, balms, and hair creams; unrefined color and fragrance are not assumed.

3. Typical use levels (formulation guide)

• Creams may use the guide range 2–8%.
• Balms and butters may use the guide range 10–25% in this reference.

Add Butyrospermum Parkii Butter through the oil phase after melting, then cool with shear to avoid a grainy texture.

4. Regulatory sources & global compliance

• A CosIng listing for Butyrospermum Parkii Butter provides ingredient information, not approval of a supplied grade or finished product.
• The framework in Regulation (EC) No 1223/2009 requires a product-level safety assessment for the complete formula that contains Butyrospermum Parkii Butter for the complete formula intended for sale.
• Establish grade-specific details for Butyrospermum Parkii Butter from the supplier and assess filing requirements in the intended market.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; this reference is not approval for drug use or OTC marketing with patch and stability testing still needed for the completed formula.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; review airless or pump options if oxidation presents a concern; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• The formulation note describes Butyrospermum Parkii Butter as part of a cosmetic direction focused on shea cushion.

• The development record cannot substantiate drug or therapeutic claims, clinical cures, or certification claims not confirmed for the product.
• The cosmetic guidance for Butyrospermum Parkii Butter cannot establish skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.